XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (2,670,469) $ (1,302,763)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 119,678 115,885
Accretion of note payable discount 31,026 5,250
Non cash interest expense 195,380 223,783
Stock based compensation 561,767 151,981
Non cash lease expense (437) 5,342
Provision for bad debt and write-off of on uncollectable accounts 82,648 29,923
Changes in operating assets and liabilities:    
Accounts receivable (191,509) (92,417)
Inventory (62,201) (103,569)
Prepaid expenses (150,982) 94,776
Deferred revenue (10,395)
Due to related parties (48,094)
Accounts payable and accrued liabilities (90,618) 386,279
Net cash used in operating activities (2,234,206) (485,530)
Investing activities    
Purchase of property and equipment (18,857) (2,138)
Net cash used in investing activities (18,857) (2,138)
Financing activities    
Payments for deferred offering costs (124,458)
Proceeds from issuance of convertible debt notes 225,000
Proceeds from issuance of loans from related parties 332,193 50,014
Proceeds from subscription advance 1,000,000
Payments of notes payable (316,920)
Net provided by financing activities 1,015,273 150,556
Net decrease in cash (1,237,790) (337,112)
Cash and cash equivalents at beginning of period 2,016,611 393,194
Cash and cash equivalents at the end of period 778,821 56,082
Supplementary cash flow disclosure    
Interest paid 7,257 9,322
Unpaid deferred offering costs $ 346,536